Tetraphase is fighting one of the most significant threats to humanity — antibiotic resistance — through the promise of our technology and the passion of our people. We are committed to making novel antibiotics accessible to all patients in need. According to The Review on Antimicrobial Resistance (May 2016), by 2050, antimicrobial resistance is projected to kill more people than cancer and diabetes combined. At Tetraphase, the fight against antimicrobial resistance is at the core of who we are as a company. It unites us in a common goal and fuels our determination to develop new antibiotics that can overcome the challenges of drug-resistant bacteria and ensure the availability of effective treatments in the future. By virtue of our size, novel technology, and well-defined mission targeting antibiotic resistance, Tetraphase has the focus and flexibility to explore a broad range of antibiotic solutions. Our lead product, XERAVA, is approved for the treatment of complicated intra-abdominal infections (cIAI), find out more at XERAVA.com
View Top Employees from Tetraphase PharmaceuticalsWebsite | http://www.tphase.com |
Ticker | TTPH |
Revenue | $5 million |
Funding | $581.2 million |
Employees | 16 (13 on RocketReach) |
Founded | 2006 |
Address | 480 Arsenal St, Watertown, Massachusetts 02472, US |
Phone | (617) 715-3600 |
Fax | (617) 926-3557 |
Technologies |
JavaScript,
HTML,
PHP
+16 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Biopharma, Antibiotics, Healthcare, Biotechnology, Gram-negative antibiotics, Health Care, Multidrug-Resistant Infections, Science and Engineering, Antibiotic Resistance, Biopharmaceutical, Bacterial Resistance |
Web Rank | 2 Million |
Keywords | Tetraphase, Ttph, Tetraphase Pharmaceuticals, Xerava Europe, Tetraphase Pipeline |
Competitors | Ardelyx, Inc., Concert Pharmaceuticals, Inc., Curza, Forge Therapeutics, Inc., Otonomy, Inc |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Tetraphase Pharmaceuticals employee's phone or email?
The Tetraphase Pharmaceuticals annual revenue was $5 million in 2024.
13 people are employed at Tetraphase Pharmaceuticals.
Tetraphase Pharmaceuticals is based in Watertown, Massachusetts.
The NAICS codes for Tetraphase Pharmaceuticals are [32, 325, 32541, 3254].
The SIC codes for Tetraphase Pharmaceuticals are [28, 283].